Exits

Namesort icon Description Event Date Acquired By
<a href="http://www.millipore.com" target="_blank">Epitome Biosystems</a> Developing novel protein measurement systems based on Protien Epitope Tag technology Acquired 2009 <a href="http://www.millipore.com" target="_blank">Millipore</a>
<a href="http://www.exactsciences.com/" target="_blank">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers IPO 2001
Genomics Collaborative Large repository of human DNA, serum and tissue samples linked to detailed clinical information Acquired 2006 <a href="http://www.seracare.com/" target="_blank">SeraCare Life Sciences</a>
<a href="http://www.lilly.com" target="_blank">Hypnion, Inc.</a> Platform technology enabling novel therapies for treatment of sleep disorders Acquired 2007 <a href="http://www.lilly.com" target="_blank">Eli Lilly</a>
<a href="http://www.idexx.com" target="_blank">IDEXX Laboratories</a> Products that enhance the ability of veterinarians to economically provide advanced medical care IPO 1991
<a href="http://www.insmed.com" target="_blank">INSMED, Incorporated</a> Pharmaceuticals for treatment of metabolic diseases and endocrine disorders IPO 2000
<a href="http://www.adt.com/medium_large_business/products_services/video_surveillance" target="_blank">IntelliVid</a> Machine intelligence for video security Acquired 2008 Tyco International
<a href="http://www.microsoft.com" target="_blank">Interactive Supercomputing Corporation</a> Software to enable applications transparent use of cluster supercomputers Acquired 2009 <a href="http://www.microsoft.com" target="_blank">Microsoft Corporation</a>
<a href="http://www.regi.com/" target="_blank">LS9</a> Leading renewable chemical technology developer. Acquired 2014
<a href="http://www.morphotek.com" target="_blank">Morphotek, Inc.</a> Genetically diverse organisms for agricultural, life science, and pharmaceutical use Acquired 2007 <a href="http://www.eisai.com" target="_blank">Eisai Company</a>
<a href="http://www.curis.com" target="_blank">Ontogeny, Inc.</a> Developmental biology insights for regenerative medicine therapies Acquired 2000 <a href="http://www.curis.com" target="_blank">Curis, Inc.</a>
<a href="http://www.appliedbiosystems.com" target="_blank">PerSeptive BioSystems</a> Developer of high-technology purification, analysis and synthesis products Acquired 1998 <a href="http://www.appliedbiosystems.com" target="_blank">Applied Biosystems</a>
<a href="http://www.shire.com/shireplc/en/home" target="_blank">Pervasis Therapeutics, Inc.</a> Developing novel therapeutics to promote vascular repair. Acquired 2012 <a href="http://www.shire.com/shireplc/en/home" target="_blank">Shire</a>
<a href="http://www.receptos.com/" target="_blank">Receptos, Inc.</a> Developing therapeutic candidates for the treatment of immune and metabolic diseases. IPO 2013
<a href="/www.evotec.com" target="_blank">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders IPO 2004
<a href="http://www.auventx.com/" target="_blank">Resolvyx Pharmaceuticals, Inc.</a> Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. Acquired 2011 <a href="http://www.celtictherapeutics.com/" target="_blank">Celtic Therapeutics</a>
Somatogen Synthetic hemoglobin products for use in blood transfusion Acquired 1998 <a href="http://www.baxter.com" target="_blank">Baxter International</a>
<a href="http://www.t2biosystems.com/" target="_blank">T2 Biosystems, Inc.</a> Developing innovative diagnostic products to improve patient health. IPO 2014
<a href="http://tphase.com/home" target="_blank">Tetraphase Pharmaceuticals, Inc.</a> Creating novel antibiotics for serious and life-threatening multidrug-resistant (MDR) bacterial infections. IPO 2013
<a href="http://www.tripadvisor.com" target="_blank">TripAdvisor LLC</a> Leading global travel information and advice destination on the web Acquired 2004 <a href="http://www.expediainc.com/" target="_blank">Expedia, Inc.</a>